Author

Evans Sagwa

Observed names: E. L. Sagwa, E. Sagwa, Evans L Sagwa, Evans L. Sagwa, Sagwa, E, Sagwa, Evans, Sagwa, Evans L.

Observed institutions: Utrecht University, University of Rwanda, Management Sciences for Health, University of the Western Cape

OpenAlex ID: A5042181453

Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort

2015 · Evans L. Sagwa, Nunurai Ruswa, et al. · BMC Pharmacology and Toxicology · 77

PDF

Antimicrobial sensitivity patterns of cerebrospinal fluid (CSF) isolates in Namibia: implications for empirical antibiotic treatment of meningitis

2013 · Assegid Mengistu, Johannes Gaeseb, et al. · Journal of Pharmaceutical Policy and Practice · 47

PDF

Adverse Events During Treatment of Drug-Resistant Tuberculosis: A Comparison Between Patients With or Without Human Immunodeficiency Virus Co-infection

2013 · Evans Sagwa, Nunurai Ruswa, et al. · Drug Safety · 31

The burden of adverse events during treatment of drug-resistant tuberculosis in Namibia.

2012 · Evans Sagwa, Aukje Kaija Mantel-Teeuwisse, et al. · Europe PMC (PubMed Central) · 30

An analysis of policies for cotrimoxazole, amoxicillin and azithromycin use in Namibia's public sector: Findings and therapeutic implications

2017 · Dan Kibuule, Mwangana Mubita, et al. · International Journal of Clinical Practice · 28

PDF

Implementing an Integrated Pharmaceutical Management Information System for Antiretrovirals and Other Medicines: Lessons From Namibia

2018 · David Mabirizi, Bayobuya Phulu, et al. · Global Health Science and Practice · 27

PDF

Oral abstracts of the 21st International AIDS Conference 18-22 July 2016, Durban, South Africa

2016 · Ericsen, A, Lauck, M, et al. · Journal of the International AIDS Society · 27

Occurrence and clinical management of moderate-to-severe adverse events during drug-resistant tuberculosis treatment: a retrospective cohort study

2014 · Evans L Sagwa, Aukje K Mantel-Teeuwisse, et al. · Journal of Pharmaceutical Policy and Practice · 21

PDF

The effect of human immunodeficiency virus infection on adverse events during treatment of drug-resistant tuberculosis: A systematic review and meta-analysis

2021 · Gilbert Lazarus, Kevin Tjoa, et al. · PLoS ONE · 17

PDF

Differences in VigiBase® reporting of aminoglycoside and capreomycin‐suspected ototoxicity during tuberculosis treatment

2016 · Evans L. Sagwa, Patrick C. Souverein, et al. · Pharmacoepidemiology and Drug Safety · 17

PDF

Assessment of the World Health Organization’s HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia

2016 · Nicholus Mutenda, Alexandra Bukowski, et al. · PLoS ONE · 15

PDF

Adverse events and patients’ perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in Namibia

2016 · Evans Sagwa, Nunurai Ruswa, et al. · Patient Preference and Adherence · 14

PDF

Active Surveillance versus Spontaneous Reporting for First-Line Antiretroviral Medicines in Namibia: A Cost–Utility Analysis

2016 · Marita Mann, Assegid Mengistu, et al. · Drug Safety · 13

Records linkage of electronic databases for the assessment of adverse effects of antiretroviral therapy in sub‐Saharan Africa

2011 · Catherine Corbell, Ishmael Katjitae, et al. · Pharmacoepidemiology and Drug Safety · 13

Renal function of MDR-TB patients treated with kanamycin regimens or concomitantly with antiretroviral agents

2017 · E. L. Sagwa, N. Ruswa, et al. · The International Journal of Tuberculosis and Lung Disease · 5

Sentinel site active surveillance of safety of first-line antiretroviral medicines in Namibia

2016 · Marita Mann, Assegid Mengistu, et al. · Pharmacoepidemiology and Drug Safety · 5

Vaccine storage and stock management practices in Vihiga County, Kenya

2024 · Eclayne Naswa Wanyonyi, Evans Sagwa, et al. · Journal of Pharmaceutical Policy and Practice · 4

PDF

Incorporating pharmaceutical supply management modules in the pre-service curriculum of the BPharm program, of the University of Namibia, School of Pharmacy

2014 · Greatjoy Njabulo Mazibuko, Evans Sagwa, et al. · Journal of Pharmaceutical Policy and Practice · 4

PDF

A Review of Empirical Treatment of Urinary Tract Infections Based on National Antimicrobial Sensitivity Data

2014 · Assegid Mengistu, Norbert Forster, et al. · Enliven Pharmacovigilance and Drug Safety · 4

Prevalence and risk factors of adverse events during treatment of drug resistant tuberculosis in a setting of high human immunodeficiency virus co-infection in Namibia : 2009-10

2012 · Evans Sagwa · University of the Western Cape Electronic Theses and Dissertations Repository (University of the Western Cape) · 2

PDF

Optimizing the Safety of Multidrug-resistant Tuberculosis Therapy in Namibia

2017 · Evans Sagwa · Utrecht University Repository (Utrecht University) · 1

Regulations in the African Union/Southern African Region (SADC Region/

2024 · Faraat Ali, Evans Sagwa, et al. · CRC Press eBooks

Data_Arthemether_Lumefantrine_Counties(1).xlsx

2022 · Kimotho, James, Abwao, Edward, et al. · Figshare

Sentinel site active Surveillance of the safety of first-line Antiretroviral medicines in Namibia

2015 · M. Mann, A. Mengistu, et al. · Value in Health

Strengthening infection prevention and control (IPC) systems in resource-limited settings using self assessment and a continuous quality improvement (CQI) approach

2015 · L. Mabuza, B. Pharasi, et al. · Journal of Patient Safety & Infection Control

Works count: 30

Citation count: 402

H-index: 13

I10-index: 14